12/01/1997
https://www.congress.gov...
which of these factors is most pressing and what recommendations on substantive solutions can we in Congress work on to ...
I resist the notion that the little ones are going to be very grateful to us for being so thorough and fair and concerne...
These regulatory requirements are an important safeguard to ensure that drugs with potentially dangerous characteristics...
We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufact...